Andreas Christensen flew the nest last year, leaving Pharmacosmos, which was founded by his paternal grandfather Henry Christensen and is still run by the family, to start biotech firm Roxiant.
He still has prominent backing, however, in the form of ALK boss Rasmus Just, who is chair of the board of Roxiant, and Kasper Gubba Ørtenblad, who is a familiar face in Danish biotech. He has taken on the role of director of operations, and a handful of other medtech and pharma players are joining the team.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.